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Summary
Background Oral rehydration solution (ORS) is a form of oral rehydration therapy (ORT) for diarrhoea that has the 
potential to drastically reduce child mortality; yet, according to UNICEF estimates, less than half of children younger 
than 5 years with diarrhoea in low-income and middle-income countries (LMICs) received ORS in 2016. A variety of 
recommended home fluids (RHF) exist as alternative forms of ORT; however, it is unclear whether RHF prevent 
child mortality. Previous studies have shown considerable variation between countries in ORS and RHF use, but 
subnational variation is unknown. This study aims to produce high-resolution geospatial estimates of relative and 
absolute coverage of ORS, RHF, and ORT (use of either ORS or RHF) in LMICs.
Methods We used a Bayesian geostatistical model including 15 spatial covariates and data from 385 household surveys 
across 94 LMICs to estimate annual proportions of children younger than 5 years of age with diarrhoea who received 
ORS or RHF (or both) on continuous continent-wide surfaces in 2000–17, and aggregated results to policy-relevant 
administrative units. Additionally, we analysed geographical inequality in coverage across administrative units and 
estimated the number of diarrhoeal deaths averted by increased coverage over the study period. Uncertainty in the 
mean coverage estimates was calculated by taking 250 draws from the posterior joint distribution of the model and 
creating uncertainty intervals (UIs) with the 2·5th and 97·5th percentiles of those 250 draws.
Findings While ORS use among children with diarrhoea increased in some countries from 2000 to 2017, coverage 
remained below 50% in the majority (62·6%; 12 417 of 19 823) of second administrative-level units and an estimated 
6 519 000 children (95% UI 5 254 000–7 733 000) with diarrhoea were not treated with any form of ORT in 2017. 
Increases in ORS use corresponded with declines in RHF in many locations, resulting in relatively constant overall 
ORT coverage from 2000 to 2017. Although ORS was uniformly distributed subnationally in some countries, within-
country geographical inequalities persisted in others; 11 countries had at least a 50% difference in one of their units 
compared with the country mean. Increases in ORS use over time were correlated with declines in RHF use and in 
diarrhoeal mortality in many locations, and an estimated 52 230 diarrhoeal deaths (36 910–68 860) were averted by 
scaling up of ORS coverage between 2000 and 2017. Finally, we identified key subnational areas in Colombia, Nigeria, 
and Sudan as examples of where diarrhoeal mortality remains higher than average, while ORS coverage remains 
lower than average.
Interpretation To our knowledge, this study is the first to produce and map subnational estimates of ORS, RHF, and 
ORT coverage and attributable child diarrhoeal deaths across LMICs from 2000 to 2017, allowing for tracking progress 
over time. Our novel results, combined with detailed subnational estimates of diarrhoeal morbidity and mortality, can 
support subnational needs assessments aimed at furthering policy makers’ understanding of within-country 
disparities. Over 50 years after the discovery that led to this simple, cheap, and life-saving therapy, large gains in 
reducing mortality could still be made by reducing geographical inequalities in ORS coverage.
Funding Bill & Melinda Gates Foundation.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Oral rehydration solution (ORS) is a simple treatment 
that can be prepared and used at home to prevent 
mortality due to dehydration and undernutrition in 
children with diarrhoea. This intervention is especially 
suitable in locations where intravenous fluids are scarce 
or unavail able,1 and replaces indiscriminate and 
unnecessary use of antibiotics to treat diarrhoea.2 ORS 
was discovered more than 50 years ago when a physician 
in Dhaka, Bangladesh, found that treating patients 
with cholera with glucose-electrolyte solutions in equiva-
lent amounts to fluid losses could prevent the need for 
intravenous liquids in 80% of patients.3 Shortly 
thereafter, its ability to prevent dehydration was shown 
in a trial in Kolkata, India,4 and during a cholera outbreak 
among Bangladeshi refugees in India.5 Since then, 
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WHO, UNICEF, and the US Centers for Disease Control 
and Prevention have promoted ORS as an essential 
medicine to treat diarrhoea, the third leading cause of 
death in children younger than 5 years of age worldwide.6 
In the 1980s, in response to low ORS coverage (ie, the 
proportion of children with diarrhoea who received 
ORS), WHO promoted the use of so-called recommended 
home fluids (RHF) in addition to ORS, and oral 
rehydration therapy (ORT) became the phrase used to 
refer to treatment with ORS or RHF.7 Despite its 
inclusion in the WHO Essential Medicines List and 
Global Action Plan for the Prevention and Control of 
Pneumonia and Diarrhoea,7–9 coverage of ORS remains 
low. According to UNICEF surveys, only 34% of children 
younger than 5 years in low-income and middle-income 
countries (LMICs) in 2000 received ORS to treat 
diarrhoea; in 2016, the proportion increased to 44%, yet 
the majority remained untreated.10
The efficacy of ORS and RHF in preventing child 
mortality relies on proper preparation of the solutions, 
which can vary depending on the resources available to 
a household. ORS is most commonly sold as premade 
packets with standardised sodium and glucose content, 
which need to be dissolved in 1 L of clean water and can 
then be stored for about 48 h.11 The cost of these packets 
varies by country; in Uganda, a single packet costs 
approximately 500 Ugandan shillings (about US$0·15),12 
and in Nigeria in 2012, the cost of three packets ranged 
from $0·63 to $4·38 depending on location.13 By 
contrast, RHF can be made with household items and 
therefore can be less costly and more widely accessible. 
The composition of RHF varies by country and can 
include carefully measured sugar and salt added to 
clean water, or it can simply include plain juice, rice 
water, tea, or coconut water.14 A meta-analysis study in 
2010 estimated that 100% coverage of ORS could prevent 
Research in context
Evidence before this study
WHO’s integrated Global Action Plan for the Prevention and 
Control of Pneumonia and Diarrhoea emphasises the need to 
make resources available to properly prevent and treat these 
childhood infections, including use of oral rehydration solution 
(ORS) to treat diarrhoea. In 2016, UNICEF published national-
level estimates of the proportion of children with diarrhoea 
who received ORS or any alternative recommended home fluids 
(RHF) for countries and years with available household survey 
data. To understand the full landscape of currently published 
estimates, we did a literature review on Feb 11, 2019, with no 
date or language restrictions. We searched the PubMed 
database for the following terms in titles or abstracts: “ORS”, 
“ORT”, “RHF”, “oral rehydration solution”, “oral rehydration 
therapy”, “oral rehydration salts”, and “recommended home 
fluids”, with the necessary inclusion of “coverage”. This returned 
229 total studies, seven of which presented or reviewed 
national-level estimates of ORS coverage globally or across 
multiple countries, and 26 of which estimated ORS or RHF 
subnational coverage in select countries. None of these studies, 
however, estimated ORS or RHF coverage subnationally across 
multiple regions or used geospatial modelling techniques to 
estimate ORS or RHF coverage in locations with sparse data.
Added value of this study
To our knowledge, this study presents the first high-resolution 
subnational estimates of the proportion and absolute number of 
children younger than 5 years with diarrhoea that received ORS 
or RHF in low-income and middle-income countries (LMICs) 
from 2000 to 2017. This work supports the examination of how 
patterns of coverage have changed over time since the 
establishment of the Millennium Development Goals in 2000, 
the identification of subnational areas in need of targeted 
interventions, and the stratification of oral rehydration therapy 
coverage into ORS and RHF estimates. We used Bayesian 
geostatistical modelling techniques and an extensive geolocated 
dataset to produce these estimates. Wherever possible, we 
tailored these methods to take into account national or 
subnational factors that might contribute to variation in ORS 
coverage, using spatially resolved covariates to estimate for areas 
with sparse data. These techniques produced estimates on 
continuous continent-wide surfaces, which we aggregated to 
policy-relevant administrative units. We show that ORS use has 
increased over time, and that increases in ORS use often 
corresponded to declines in RHF use to treat diarrhoea and in 
diarrhoeal mortality rate. We estimate that scaling up of ORS 
treatment over the study period prevented an estimated 
52 230 deaths (36 910–68 860) across LMICs in 2017. Despite 
progress, coverage of ORS (ie, the proportion of children with 
diarrhoea who received ORS) remained below 50% in many 
locations where diarrhoea prevalence and mortality rates remain 
high. Importantly, we also show that while within-country 
geographical inequalities declined over time, large disparities 
remained in multiple countries with high diarrhoeal burden, 
including subnational areas of Colombia, Peru, Nigeria, and 
Sudan.
Implications of all the available evidence
Our mapped estimates identify areas with low ORS usage, 
which could indicate gaps in access to ORS or knowledge of its 
efficacy to treat diarrhoea, and illuminate areas where 
improvements in ORS coverage are needed. Together with 
maps of other key risk factors, including sanitation and 
childhood stunting, these results can be used to develop 
integrated strategies that prevent diarrhoeal morbidity and 
mortality on a local level. These estimates and corresponding 
visualisation tools can aid policy makers and public health 
practitioners in determining where increased efforts to reduce 
geographical inequalities in ORS coverage are needed to make 
further strides in reducing mortality with this simple therapy.
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93% of diarrhoeal deaths, yet found insufficient 
evidence on the effectiveness of RHF in preventing 
mortality, probably due to the broad range in RHF 
composition.14
To understand trends in diarrhoeal deaths and ORT 
coverage across space and time, it is crucial to analyse 
ORS and RHF treatment separately. A study in Ethiopia 
found subnational geographical variation in ORT 
coverage, which was driven primarily by differences in 
wealth.15 A recent study including data from 88 LMICs 
showed an 8 percentage-point difference in ORT 
coverage on average between the wealthiest and poorest 
household quintiles, which was low compared with 
other interventions such as improvements to water 
and sanitation.16 These studies, however, did not analyse 
ORS and RHF separately and might have under-
estimated variation. Other studies have shown that 
ORS use can vary broadly between countries, even 
between those sharing borders.11,17 Additionally, studies 
have shown differences in ORS use between urban 
and rural populations in Kenya18 and Mexico.19 These 
findings suggest that there are subnational drivers 
of variation in ORS coverage, and that these drivers 
can differ between geographical regions. Moreover, 
pre vious studies showed subnational variation in 
diarrhoeal deaths and overall deaths in children younger 
than 5 years,20–22 some of which might be driven by 
subnational variation in ORS given its efficacy in 
reducing child mortality.
Furthermore, policies related to diarrhoea treatment 
set at the national level do not affect all subnational areas 
equally, and interventions are often implemented at the 
subnational level, such as those currently done in 
Nigeria and India.23,24 Local-level estimates of ORS and 
RHF coverage are thus needed to identify vulnerable 
subpopulations most in need of increased efforts to 
prevent child mortality. Yet, to our knowledge, no study 
has estimated ORS coverage subnationally across 
multiple regions or has used geospatial modelling 
techniques to estimate ORS coverage in locations with 
sparse data, and no study has compared ORS coverage to 
patterns in RHF coverage.
Our aim in this study was to estimate the proportions 
of children with diarrhoea who were treated with ORS 
and RHF (ie, ORS and RHF coverage, respectively) over 
space and time in LMICs and examine geographical 
inequalities within countries. Here we present, to our 
knowledge, the first maps of ORS or RHF coverage for 
second admini strative-level units (eg, districts, counties; 
henceforth referred to as units) in LMICs. We present 
both relative quantities (proportion of children) and 
absolute quantities (number of children), as these 
measures have distinct policy implications. We conclude 
by highlighting countries with some of the broadest 
differences in coverage across subnational units, which 
also have high diarrhoeal burdens and high subnational 
variation in mortality.
Methods
Definitions
For this study, ORS was defined as a pre-packaged 
electrolyte solution containing glucose or another form 
of sugar or starch, as well as sodium, chloride, potassium, 
and bicarbonate.14 Survey questions did not allow us to 
separate RHF into their different formulations; therefore, 
RHF were defined as all possible home fluid alternatives, 
including sugar-salt solution, cereal-salt solution, rice-
water solution, and additional fluids, such as plain water, 
juice, tea, or rice water.14 To account for this variation, we 
adjusted all non-standard RHF definitions to the most 
common or standard definition across all surveys, using 
logistic regression to determine adjustments (appendix 1 
p 3). ORT was defined as treatment with either ORS, 
RHF, or both. Coverage was defined as the proportion of 
children younger than 5 years of age with diarrhoea who 
received ORS, RHF, or ORT. Diarrhoea was defined as 
three or more abnormally loose or watery stools within a 
24-h period.
Data
We compiled 385 household surveys (including 
Demographic and Health Surveys, Multiple Indicator 
Cluster Surveys, and other country-specific surveys) repre-
senting 3 609 000 children with diarrhoea in 94 LMICs 
from 2000 to 2017, with geocoded information from 
120 742 coordinates corresponding to survey clusters and 
14 055 subnational polygon boundaries where point-level 
referencing was not available (appendix 1 p 4). We included 
surveys that asked if children younger than 5 years with 
diarrhoea received any kind of ORT, allowed for geolocation 
below the country level, and were representative of the 
populations in which they were conducted. We included 
surveys for countries classified as low income or middle 
income on the basis of their Socio-demographic Index 
(SDI) quintile: low SDI, low-middle SDI, or middle SDI.25 
SDI, developed as part of the Global Burden of Diseases, 
Injuries, and Risk Factors Study (GBD), indicates the level 
of development based on a country’s average education, 
fertility, and income, and is on a scale of 0 to 1.25 Only 
LMICs with relevant and available underlying data were 
included in subsequent analyses, and island nations 
with fewer than 1 million inhabitants were excluded 
(appendix 1 p 4). This study complied with the Guidelines 
for Accurate and Transparent Health Estimates Reporting 
recom mendations (appendix 1 pp 85–86).26 Further details 
on data inclusion, coverage, and validation can be found in 
appendix 1 (pp 4, 8).
We compiled 15 spatial covariates that were indexed at 
the subnational level for all 94 countries included in the 
study and that had conceivable relationships with ORT, 
which were used as predictors in our model. Covariates 
related to urbanicity or access to cities were night-time 
lights, population, urban or rural location, urban 
proportion of the location, and access to cities. Covariates 
related to child health, support, and nutrition were 
See Online for appendix 1
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prevalence of under-5 stunting, prevalence of under-5 
wasting, ratio of child dependents (ages 0–14 years) to 
working adults (ages 15–64 years), number of children 
younger than 5 years per woman of childbearing age, 
number of people whose daily vitamin A needs could be 
met, and maternal education. Covariates related to 
environmental factors that might affect diarrhoeal burden, 
which might in turn affect ORS supply, were aridity, 
distance from rivers or lakes, elevation, and irrigation. We 
also included the Healthcare Access and Quality Index27 
and the proportion of pregnant women who received four 
or more antenatal care visits as national-level covariates. 
We filtered these covariates for multicollinearity within 
each modelling region (appendix 1 p 5) using variance 
inflation factor (VIF) analysis with a VIF threshold of 3.28 
Detailed covariate information can be found in 
appendix 1 (p 5).
Statistical analysis
Analyses were done using R version 3.5.0. ORS, RHF, 
and ORT coverage were modelled separately using a 
Bayesian model-based geostatistical framework. Briefly, 
this framework uses a spatially and temporally explicit 
hierarchical logistic regression model to predict coverage 
in all locations, assuming that points that are closer 
together in space and time and that have similar covariate 
patterns have similar coverage. Potential non-linear 
relationships between covariates and coverage were 
incorporated through the use of a stacked generalisation 
technique.29 Posterior distributions of all model param-
eters and hyperparameters were estimated using the 
statistical package R-INLA (version 19.05.30.9000).30,31 
Uncertainty in the mean coverage estimates was 
calculated by taking 250 draws from the posterior joint 
distribution of the model, and each point value is reported 
with an uncertainty interval (UI), which represents the 
2·5th and 97·5th percentiles of those 250 draws. Maps 
were produced using ArcGIS Desktop 10.6. Models were 
run independently in 14 geographically distinct modelling 
regions based on GBD,32 and an additional nine country-
specific models due to distinct temporal patterns of 
ORS coverage in these countries compared with their 
surrounding regions. Additional methodological details 
can be found in appendix 1 (pp 5–7).
Models were validated using five-fold cross-validation. 
Holdout sets were created by combining randomised 
sets of datapoints at the second administrative-unit 
cluster level. Model performance was summarised by the 
bias (mean error), total variance (root-mean-square 
error), and 95% data coverage within prediction intervals, 
and correlation between observed data and predictions. 
Where possible, estimates from these models were 
compared against other existing estimates. All validation 
procedures and corresponding results are provided in 
appendix 1 (p 8).
We calculated population-weighted aggregations of the 
250 draws of ORS, RHF, and ORT coverage estimates at 
the country level, first administrative-level unit, and 
second administrative-level unit. To quantify geographical 
inequalities within countries over time, we used three 
different measures of inequality, each with their own 
strengths. We calculated Gini coefficients as a summary 
measure of inequality at the country level;33 in brief, the 
Gini coefficient summarises the distribution of each 
indicator across the population, with a value of 0 repre-
senting perfect equality and a value of 1 representing 
maximum inequality (appendix 1 p 9). We quantified 
absolute percentage-point deviation from the country 
mean to illustrate the total percentage-point difference in 
coverage between each unit and its country mean. Finally, 
we used relative deviation from the country mean to 
illustrate the difference in ORS coverage between each 
unit and its country mean.
To investigate the relationship between ORT and 
diarrhoeal mortality, we used mortality estimates from 
Reiner and colleagues34 and compared them with ORS 
coverage at the country and second administrative-unit 
levels. In addition, we did a counterfactual analysis to 
determine the estimated number of deaths averted due 
to changes in ORS coverage between 2000 and 2017, 
which is described in detail in appendix 1 (pp 9–10). In 
the counterfactual analysis, we treated ORS coverage as 
an independent risk factor and did not take into account 
how changes in demography or other risk factors affect 
deaths. We additionally did a sensitivity analysis of these 
results by halving and doubling the estimated lives that 
could be saved with ORS treatment14 (appendix 1 pp 82–83).
Role of the funding source
This research was supported by the Bill & Melinda Gates 
Foundation. The funder had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
In all years from 2000 to 2017, we found both between-
country and within-country variation in the proportion of 
children younger than 5 years with diarrhoea who 
received ORT. In general, ORS coverage was highest in 
south Asia, east Asia, central America, and southern sub-
Saharan Africa, and lowest in central sub-Saharan Africa, 
parts of western and eastern sub-Saharan Africa, the 
Middle East, and South America (figure 1). Within these 
regions, some countries had fairly uniform subnational 
distribution of ORS across units, such as Zimbabwe in 
2017, where coverage ranged from 35·1% (95% UI 
11·8–66·6) in Chivi district, Masvingo province, to 44·6% 
(16·2–76·7) in Mazowe district, Mashonaland Central 
province. Other countries had notable subnational 
variation, such as Peru in 2017, where coverage ranged 
from 16·1% (12·1–20·6) in Azángaro province, Puno 
region, to 45·2% (38·2–51·5) in Trujillo province, 
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Figure 1: Proportion of 
children younger than 
5 years with diarrhoea who 
received ORT at the second 
administrative-unit level, 
2000 and 2017
Mean proportion of children 
with diarrhoea who received 
ORS in 2000 (A) and 2017 (B) 
or who received RHF in 
2000 (C) and 2017 (D). All 
countries are aggregated to 
second administrative units. 
Maps reflect administrative 
boundaries, land cover, lakes, 
and population. Dark grey grid 
cells were classified as barren 
or sparsely vegetated and had 
fewer than ten people per 
1 km × 1 km grid cell; light grey 
countries were not included in 
these analyses.35–40 ORS=oral 
rehydration solution. 
ORT=oral rehydration therapy. 
RHF=recommended home 
fluids.
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La Libertad region (figure 1B). In terms of absolute 
coverage, RHF coverage was lower and more evenly 
distributed in Peru in 2017, with coverage ranging from 
5·0% (2·9–8·5) in Coronel Portillo province, Ucayali, to 
19·7% (12·3–28·9) in Daniel Alcides Carrión province, 
Pasco (figure 1D). Across all LMICs, ORS coverage 
remained below 50% in 62·6% (12 417 of 19 823) of units 
in 2017.
Although most changes were small, we found that 
ORS coverage increased while RHF coverage decreased 
between 2000 and 2017 in many locations (figure 1). We 
found significant increases in ORS coverage nationally 
and subnationally in Rwanda, Vietnam, Bolivia, 
Cambodia, and India (figure 1; appendix 1 p 75; 
appendix 2 pp 1–8, 25–1615), and significant declines in 
RHF coverage in Rwanda, Burundi, Bolivia, Niger, Chad, 
and India (figure 1; appendix 1 p 76; appendix 2 pp 9–16, 
1616–3206). In Rwanda, ORS coverage increased from 
12·0% (95% UI 9·8 to 14·6) to 33·9% (22·9 to 45·4), 
with an annualised rate of change (AROC) of 10·7% 
(3·2 to 17·6). At the same time, RHF coverage decreased 
from 28·1% (16·1 to 41·6) to 10·7% (3·3 to 25·8), with 
an AROC of −2·8% (−28·3 to 19·7). Increases in ORS, as 
measured by AROC, were significant (ie, 95% UIs did 
not include 0) in 27 of Rwanda’s 30 units, while overall 
ORT coverage remained constant (appendix 1 pp 75–77; 
appendix 2 pp 1–8, 3207–4797). Kyrgyzstan, Yemen, and 
Liberia saw the largest increases in RHF coverage; 
however, uncertainty around these estimates was high, 
and only Yemen saw significant increases in RHF use 
(appendix 1 p 76; appendix 2 pp 9–16). Sudan and South 
Sudan were the only countries where AROC in ORS 
coverage declined substantially, with coverage decreasing 
from 32·3% (26·5 to 38·3) to 19·7% (14·6 to 26·2) in 
Sudan and from 52·0% (41·6 to 62·2) to 48·4% 
(37·6 to 59·5) in South Sudan. Declines were significant 
in eight of Sudan’s 80 units and four of South Sudan’s 
45 units (figure 1; appendix 1 p 75; appendix 2 pp 1–8, 
25–1615).
In 2017, the highest number of children with diarrhoea 
who remained untreated by ORS were in parts of 
eastern sub-Saharan Africa, north Africa, south Asia, 
and southeast Asia (figure 2). In 2000, we estimated 
that approxi mately 6 668 000 children (95% UI 
5 330 000–7 673 000) across the 94 LMICs included in this 
study were untreated with either ORS or RHF, out of a 
total of 12 873 000 children (12 344 000–13 471 000) with 
diarrhoea. Although prevalence of untreated children has 
declined, a substantial number remain in need of 
treatment; in 2017, we estimated 6 519 000 children 
(95% UI 5 254 000–7 733 000) with diarrhoea did not 
receive either ORS or RHF treatment, out of a total of 
13 343 000 children (12 709 000–13 944 000) with diarrhoea, 
and this burden varied substantially within many 
countries (figure 2).
In addition to the results presented here, the full 
array of our model outputs for ORS, RHF, or ORT 
(either ORS or RHF) is provided in appendix 1 
(pp 28–36) and is publicly available online, and can be 
further explored at various spatial levels via a user-
friendly visualisation tool.
We found that inequality in ORS coverage, as measured 
by the Gini coefficient, decreased in the majority 
(63 [67%]) of countries from 2000 to 2017. In particular, 
although there were nine countries (Afghanistan, 
Cambodia, Cameroon, Côte d’Ivoire, Equatorial Guinea, 
Guinea, Iraq, Mali, and Mauritania) in 2000 whose Gini 
coefficient was greater than 0·15, only Afghanistan and 
Cameroon had coefficients above 0·15 in 2017.
Absolute percentage-point differences between units 
with the highest and lowest ORS coverage declined in 
40 countries, with notable decreases in Equatorial 
Guinea, Central African Republic, Iraq, Mongolia, 
Myanmar, and Sierra Leone (figure 3). Absolute 
inequalities increased in more than half (54 [57%]) of 
LMICs, with notable increases in Jordan, Colombia, 
Uzbekistan, Afghanistan, Bolivia, Turkmenistan, 
Palestine, Benin, and Madagascar (figure 3). By contrast, 
within-country absolute geo graphical inequali ties in 
RHF coverage declined in most (55 [59%]) countries, 
with notable exceptions in Yemen and Tajikistan 
(appendix 1 p 79).
Analysis of relative deviation from the country mean 
revealed that 11 LMICs (Afghanistan, Benin, Cameroon, 
Democratic Republic of the Congo, Colombia, Ethiopia, 
Guinea, Jordan, Nigeria, Sudan, and Uganda) had at 
least 50% relative deviation in one of their units 
in ORS use in 2017 (figure 3). Additionally, as mean 
national-level ORS coverage increased over time in 
most (76 [81%]) countries (appendix 1 p 78), within-
country relative differences in ORS coverage also 
declined in 64 (68%) LMICs, with greater than 50% 
declines in relative deviation in Central African 
Republic, Equatorial Guinea, Iraq, Mali, Cambodia, 
Ethiopia, Niger, Senegal, Kyrgyzstan, Togo, Democratic 
Republic of the Congo, and Côte d’Ivoire (figure 3). 
Exceptions to this pattern, where relative differences 
increased more than 20%, included Jordan, Benin, 
Madagascar, Yemen, Sudan, Suriname, Guatemala, 
Turkmenistan, and Bolivia. Further more, as mean 
national-level RHF coverage declined over time in most 
(69 [73%]) countries, within-country relative inequalities 
in RHF coverage declined in 45 (48%) countries 
(appendix 1 p 78). In 2017, relative inequalities in RHF 
coverage remained highest in North Africa and the 
Middle East (appendix 1 p 78).
We found that mean ORS coverage was less than 50% 
in 12 of 14 countries where diarrhoeal mortality in 2017 
was greater than two children per 1000 (appendix 2 pp 1–8). 
Furthermore, we found that ORS coverage was negatively 
correlated with RHF coverage over time in 56·6% 
(10 786 of 19 064) of units and was negatively correlated 
with diarrhoeal mortality over time in 74·7% (14 241 of 
19 064) of units (appendix 1 p 81).
For full model outputs see 
http://ghdx.healthdata.org/
record/ihme-data/lmic-oral-
rehydration-therapy-coverage-
geospatial-estimates-2000-2017
For the visualisation tool see 
https://vizhub.healthdata.org/
lbd/ort
See Online for appendix 2
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Figure 2: Number of children 
younger than 5 years with 
diarrhoea who did not 
receive ORT at the second 
administrative-unit level, 
2000 and 2017
Number of children younger 
than 5 years with diarrhoea 
who did not receive ORS in 
2000 (A) and 2017 (B) or did 
not receive ORT (either ORS or 
RHF) in 2000 (C) and 2017 (D). 
Countries are aggregated to 
second administrative units. 
Maps reflect administrative 
boundaries, land cover, lakes, 
and population. Dark grey grid 
cells were classified as barren 
or sparsely vegetated and had 
fewer than ten people per 
1 km × 1 km grid cell; light grey 
countries were not included in 
these analyses.35–40 ORS=oral 
rehydration solution. 
ORT=oral rehydration therapy. 
RHF=recommended home 
fluids.
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To illustrate how our maps can be used to estimate 
the number of diarrhoeal deaths that were averted 
by changes in ORS coverage, we did a counterfactual 
analysis using a previous estimate that 75% ORS 
coverage could reduce diarrhoeal deaths by 69%.14 This 
estimate is based on a systematic review of three quasi-
experimental studies with small sample sizes and that 
did not adjust for confounding variables (eg, stunting) to 
examine the risk of death in the absence of ORS 
treatment; thus, the results of this analysis should be 
interpreted with some caution. We found that of the 
526 800 diarrhoeal deaths (95% UI 485 300–568 900) 
estimated to have occurred in 2017 in children younger 
than 5 years across the 94 LMICs included in our 
analysis, an estimated 299 900 deaths (274 000–324 300) 
could be attributable to lack of treatment with ORS. We 
also estimated that increase in ORS coverage during the 
study period prevented an additional 52 230 deaths 
(36 910–68 860). Nigeria, India, Ethiopia, Pakistan, Chad, 
and Madagascar contained units with high numbers of 
deaths attributable to lack of ORS treatment in 2017; 
however, these countries also contained units with the 
highest numbers of deaths averted by improved ORS 
coverage in 2017 (figure 4). By contrast, an estimated 
4850 deaths (2200–10 080) globally were due to declines 
in ORS coverage, with some of the highest numbers of 
deaths attributable to worsening coverage in units of 
Sudan, South Sudan, and Pakistan (figure 4). Some of 
the highest rates of deaths averted were in units of Sierra 
Leone, where 0·9 deaths (0·2–1·9) were averted per 
1000 children in Kambia district, Northern Province 
(figure 4), corresponding to 67 lives (18–141) saved in 
2017 in this district alone.
In a sensitivity analysis, we found that, while the 
geographical patterns in deaths averted remained largely 
unchanged, the absolute number of averted deaths 
changed substantially in some places (appendix 1 
pp 82–83). Reducing the percentage of diarrhoeal deaths 
that could be averted with ORS from 69% to 35% reduced 
the total number of deaths attributable to lack of ORS 
Figure 3: Geographical inequalities within countries in the proportion of children with diarrhoea who received ORS, 2000 and 2017
(A) Bars show range of ORS coverage at the second administrative-unit level for each country in 2000 (shown in grey) and 2017 (coloured by region), with the mean proportion (national-level 
aggregations) marked with a dot in each bar. (B) Bars show range of relative deviation from the country mean in the proportion of children younger than 5 years with diarrhoea who received ORS in 
2000 (shown in grey) and 2017 (coloured by region). Countries are labelled by their ISO 3 codes. Geographical inequality in ORS coverage for each country is shown in detail in appendix 1 (p 78); 
inequalities in RHF and ORT coverage are shown in appendix 1 (pp 79–80). ORS=oral rehydration solution. ORT=oral rehydration therapy. RHF=recommended home fluids.
25
0
50
75
KG
Z
M
N
G
UZ
B
TJ
K
PA
N
EC
U
PE
R
PR
Y
BO
L
SU
R
H
TI CR
I
GU
Y
DO
M
GT
M
BL
Z
M
EX CO
L
JA
M
H
N
D
N
IC SL
V
SD
N
M
AR EG
Y
IR
Q
YE
M
DZ
A
JO
R
PH
L
PS
E
AF
G
SY
R
TU
N
N
PL PA
K
IN
D
BT
N
BG
D
PN
G
ID
N
KH
M
LK
A
VN
M
LA
O
M
M
R
TH
A
TL
S
TC
D
BF
A
CM
R
M
DG TG
O
CA
F
M
LI
SE
N
CO
G
BE
N
N
GA M
RT
SO
M
GA
B
ET
H
N
ER
GN
B
GI
N
RW
A
BD
I
CO
D
ZW
E
CO
M
GH
A
ER
I
GN
Q
AG
O
UG
A
BW
A
SS
D
TZ
A
KE
N
GM
B
ZA
F
TK
M
M
O
Z
LS
O
M
W
I
DJ
I
ZM
B
N
AM LB
R
SL
E
SW
Z
Pe
rc
en
ta
ge
 o
f c
hi
ld
re
n 
w
ith
 d
ia
rrh
oe
a 
w
ho
 re
ce
iv
ed
 O
RS
GBD super-region
Central Europe, eastern Europe, and central Asia
Latin America and Caribbean
North Africa and Middle East
South Asia
Southeast Asia, east Asia, and Oceania
Sub-Saharan Africa
–0.5
0.0
0.5
1.0
KG
Z
M
N
G
UZ
B
TJ
K
PA
N
EC
U
PE
R
PR
Y
BO
L
SU
R
H
TI CR
I
GU
Y
DO
M
GT
M
BL
Z
M
EX CO
L
JA
M
H
N
D
N
IC SL
V
SD
N
M
AR EG
Y
IR
Q
YE
M
DZ
A
JO
R
PH
L
PS
E
AF
G
SY
R
TU
N
N
PL PA
K
IN
D
BT
N
BG
D
PN
G
ID
N
KH
M
LK
A
VN
M
LA
O
M
M
R
TH
A
TL
S
TC
D
BF
A
CM
R
M
DG TG
O
CA
F
M
LI
SE
N
CO
G
BE
N
N
GA M
RT
SO
M
GA
B
ET
H
N
ER
GN
B
GI
N
RW
A
BD
I
CO
D
ZW
E
CO
M
GH
A
ER
I
GN
Q
AG
O
UG
A
BW
A
SS
D
TZ
A
KE
N
GM
B
ZA
F
TK
M
M
O
Z
LS
O
M
W
I
DJ
I
ZM
B
N
AM LB
R
SL
E
SW
Z
Country
Re
la
tiv
e 
de
vi
at
io
n
A ORS coverage
B Relative deviation from country mean
For ISO 3 codes see https://www.
iso.org/obp/ui
Articles
www.thelancet.com/lancetgh   Vol 8   August 2020 e1046
coverage in 2017 from 299 900 (95% UI 274 000–324 300) 
to 143 360 (130 400–156 000), the estimated total deaths 
averted by increase in ORS coverage from 52 230 
(36 910–68 860) to 22 760 (15 600–30 650), and the averted 
deaths in Kambia district, Sierra Leone, from 67 (18–141) 
to 26 (8–53; appendix 1 p 82).
Figure 4: Averted child 
diarrhoeal deaths 
attributable to increased ORS 
coverage from 2000 to 2017
(A) Number of deaths in 
children younger than 5 years 
attributable to lack of ORS 
treatment in 2017. (B) Number 
of deaths in children younger 
than 5 years in 2017 averted 
by and attributable to changes 
in ORS coverage between 
2000 and 2017. (C) Number of 
deaths per 1000 children 
younger than 5 years in 2017 
averted by and attributable to 
changes in ORS between 2000 
and 2017. Maps reflect 
administrative boundaries, 
land cover, lakes, and 
population. Dark grey grid cells 
were classified as barren or 
sparsely vegetated and had 
fewer than ten people per 
1 km × 1 km grid cell; light grey 
countries were not included in 
these analyses.35–40 ORS=oral 
rehydration solution.
Number of attributable deaths
>500500
Deaths averted 
by change
0 >100102>20
Deaths attributable 
to change
00·02 0·05 >0·50>0·20
Deaths averted 
by change 
per 1000 children
Deaths attributable 
to change
per 1000 children
A
B
C
Articles
e1047 www.thelancet.com/lancetgh   Vol 8   August 2020
Finally, to illustrate how these maps can be used to 
identify children in need, we present side-by-side maps 
of diarrhoeal mortality, ORS coverage, and RHF coverage 
at the unit level for three countries—Colombia, Nigeria, 
and Sudan—that had subnational locations with higher-
than-average mortality rates and lower-than-average ORS 
coverage (figure 5). In Colombia, ORS and RHF coverage 
were lowest in the southern Amazonas region, where 
diarrhoeal burden was highest. In Nigeria, ORS coverage 
was lowest in the northern region, where diarrhoeal 
burden was highest. In Sudan, RHF remains widely used 
to treat diarrhoea, and there was not a clear trend between 
ORS, RHF, and diarrhoea distributions, but distinct 
areas in Darfur, in the southeast of the country, had high 
diarrhoeal mortality and particularly low ORS coverage. 
To illustrate that this pattern was not present everywhere, 
we also present results for Peru, where ORS coverage 
was relatively high in the Amazon Basin rainforests, 
which is where diarrhoeal mortality was also highest. 
There were gaps in coverage in the mountainous and 
arid regions of central and south Peru, where diarrhoeal 
mortality was lower (figure 5).
Discussion
The discovery that led to the development of ORS as 
treatment for diarrhoea was hailed as “potentially the 
most important medical advancement of the century”.41 
More than 50 years later, ORS is recognised as an 
important treatment for childhood diarrhoea, as well as a 
crucial component in treating other forms of dehydration, 
including dehydration-induced kidney injury and Ebola 
virus disease.42 By providing high-resolution estimates of 
the use of different forms of ORT—ORS, RHF, and 
either ORS or RHF—in children younger than 5 years 
with diarrhoea in LMICs, this study examines where 
uptake has occurred and which places stand to gain the 
most. While we show increases in ORS coverage in many 
locations, it is striking that these increases have been so 
incremental, given the importance and simplicity of this 
intervention. These slow changes are reflected in the 
relatively low number of total deaths estimated to have 
been averted by increases in ORS coverage between 
2000 and 2017, and the substantial number of children 
with diarrhoea that remained untreated in 2017. ORS 
coverage remains below 50% in the majority (62·6%) of 
second administrative units, and there are various 
locations with high diarrhoeal mortality rates where 
geographical inequalities in ORS coverage are high. 
These areas need to be targeted with improved efforts to 
increase access to and awareness of this life-saving 
treatment.
We also show that increases in ORS coverage over time 
were correlated with declines in RHF coverage in many 
locations. It is possible that these results represent shifts 
over time in diarrhoea treatment, which might have 
contributed to declines in diarrhoeal mortality in these 
locations; ORS has shown effectiveness in preventing 
child mortality, whereas the effect of RHF on child 
mortality is unclear.14 However, if the rates of decline in 
RHF exceeded the rates of increase in ORS in some 
locations, this could have left a proportion of children 
Figure 5: Subnational variation in the 2017 proportions of children who received ORT and diarrhoeal 
mortality in countries with high diarrhoeal burden at the second administrative-unit level
Subnational variation in ORS, RHF, and diarrhoeal mortality per 1000 children is shown in four countries that had 
both high diarrhoeal burden and high geographical inequality in ORT in 2017. Results are shown for 2017 at second 
administrative units. Maps reflect administrative boundaries, land cover, lakes, and population. Dark grey grid cells 
were classified as barren or sparsely vegetated and had fewer than ten people per 1 km × 1 km grid cell.35–40 ORS=oral 
rehydration solution. ORT=oral rehydration therapy. RHF=recommended home fluids.
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completely untreated and in need of targeted inter-
ventions to prevent diarrhoeal mortality. These results 
further highlight the importance of reaching these 
vulnerable populations with targeted interventions to 
improve ORS coverage. It is important to note that there 
were also locations where there was apparently no 
relationship between ORS coverage and diarrhoeal 
mortality over time. This could, in part, be attributed to 
other risk factors that affect diarrhoeal mortality, which 
we did not take into account in this analysis.
Our estimates are comparable with previously published 
estimates at the national level.10,11 We show notable 
differences in ORS coverage between countries in the 
same region (eg, Senegal vs Sierra Leone), consistent with 
a previous review.8 We show that ORS use has increased 
over time, with greater uptake in some regions compared 
with others (eg, south Asia vs the Horn of Africa), which is 
consistent with the conclusions of UNICEF’s 2016 
report.8,10 However, we also show that the rates of increase 
in ORS coverage and decrease in RHF coverage were 
modest and that uncertainty in these estimates was high, 
which is consistent with previous studies that showed 
no substantial increases in ORT coverage between 
1990 and 200143 or between 1996 and 2003.44 We also show 
that relative and absolute geographical inequalities in 
ORS coverage declined over time in many countries, 
which is in contrast with a previous study that showed that 
absolute inequalities in ORT have remained the same 
over time in all but three LMICs.16 There are numerous 
methodological differences between that study and ours; 
most importantly, the previous study did not separate the 
effect of ORS from that of RHF. As we show, analysis of 
ORT (a combined variable) masks spatial and temporal 
variation in ORS and RHF.
We are surprised to see low use of ORS after so many 
years of programmes in many countries, especially those 
with high diarrhoeal burden. Ensuring access to ORS 
treatment is not only important for treating existing 
diarrhoea cases, but also in preparing for outbreaks and 
having supplies ready for emergencies. Moreover, edu-
cating caregivers on the causes of diarrhoea mortality—
and how ORS can prevent those child deaths—is essential 
to ensure sustainable uptake. To address shortfalls in 
coverage, it will be essential to examine the root causes 
specific to each location. Previous studies have shown that 
challenges in using ORS include doctor and patient 
knowledge about ORS; ORS supply, cost, and taste; and 
access to clean water.11,45 Studies have also shown that 
improvements in ORS coverage can be driven by changes 
in government policies, media campaigns, and community 
culture and beliefs.2,23,24 According to our results, Sierra 
Leone had some of the highest ORS coverage in western 
sub-Saharan Africa in 2017. Sierra Leone has previously 
been described as an example of how community 
mobilisation can promote access to and awareness of ORS, 
even after a devastating civil war.11 Our results also suggest 
that promotion of RHF over ORS might negatively affect 
ORS use and that locations with high RHF use, such as 
Sudan, can have very low ORS coverage. A previous study 
has similarly shown that inconsistent and unclear 
diarrhoea treatment recom mendations present challenges 
in Sudan and Somalia and might have had implications for 
the recent cholera epidemic in Yemen.46 By determining 
key country-specific drivers of low uptake and subnational 
inequalities, including various social, cultural, political, 
and economic factors that might inhibit proper coverage, 
successful interventions such as those in Sierra Leone 
could be adapted and applied to similar contexts.
Our study has several limitations. Although we 
constructed a large database of geolocated ORT coverage 
data, spatial and temporal gaps remain, and data quality 
is likely to be variable by source, contributing to 
uncertainty in our estimates. Thus, results from zones of 
conflict and political instability, such as Yemen, Syria, 
Iraq, Afghanistan, and Pakistan, should be interpreted 
with caution. For RHF modelling, we included a broad 
range of RHF definitions in the survey data, and the 
RHF definitions in survey questionnaires do not always 
correspond to the actual solutions that governments have 
recommended. In addition, since the denominator of our 
input data was the proportion of children with diarrhoea 
(ie, diarrhoea prevalence), sample sizes were very small. 
Finally, heterogeneity within the data as well as amount 
of relevant available data varied between countries. Each 
of these factors probably contributed to uncertainty in 
our estimates, which varied by indicator and country 
(appendix 2).
As a further limitation, the modelling framework was 
optimised for prediction rather than causal inference, 
and there were overlaps between covariates used to 
estimate ORS, RHF, and diarrhoeal mortality, so we 
cannot make any conclusions about causal relationships 
between them. Additionally, we were unable to incor-
porate uncertainty into our estimates of the number of 
children with diarrhoea who were untreated because 
uncertainty from WorldPop datasets35 was not available. 
Furthermore, we fit our models using survey data, which 
depend on recall and are susceptible to biases that could 
be in the direction of increased or decreased coverage, 
depending on the context. Lastly, we mapped the reported 
use of ORS, yet use is not equivalent to proper preparation 
of the solution.47,48
Future studies should examine the factors that have 
affected ORS coverage, particularly those that have 
contributed to shortfalls in efforts to increase coverage, to 
inform future interventions and implementation studies. 
Future work should also further investigate coverage of 
zinc treatment, which has shown effectiveness in reducing 
undernourishment and diarrhoeal mortality in many 
countries.49 In addition, promoting zinc use has shown a 
secondary effect of increasing ORS use in some places;50,51 
thus comprehensive approaches to overcome challenges 
to uptake and scaling up of coverage are warranted.52 
Future work could investigate how missing data affect 
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estimates of ORS coverage and how to account for this, as 
well as how to incorporate differences between urban and 
rural populations into the analysis. In addition, we did not 
map ORS availability, but rather the prevalence of its use, 
and future studies could map availability distribution 
patterns. Future work should examine the co-distribution 
of different interventions to prevent childhood mortality 
from diarrhoea, such as the co-distributions of ORS, zinc, 
and access to clean water. Finally, as with any study that 
involves estimation, the availability and quality of input 
data influences the certainty of our estimates; as LMICs 
work to improve their cause-specific vital registration 
systems, analyses that incorporate diarrhoea-specific 
cause of death data in estimates of diarrhoea mortality 
would improve future updates to this work.
In conclusion, our results show that advancement 
in ORS coverage was slow from 2000 to 2017, and that 
within-country inequalities in ORS coverage persist in 
many LMICs. Depending on the local context, low levels 
of coverage might reflect challenges in access to ORS 
or the need for education on the efficacy of ORS 
in preventing diarrhoea mortality. Increased efforts are 
needed, particularly where childhood deaths from 
diarrhoea are high yet ORS coverage remains low; in 
2017, 12 of 14 LMICs where diarrhoeal mortality exceeded 
two children per 1000 had less than 50% ORS coverage. 
The subnational scale of these mapped estimates can aid 
in identifying where gaps in coverage of this life-saving 
intervention remain, contributing to the UN Sustainable 
Development Goals’ commitment to address inequalities 
and leave no one behind.53 Our results illustrate that 
scaling up of ORS coverage has been insufficient, and 
that new efforts to improve access are desperately 
needed.
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